Implementation of an electronic early treatment assessment and monitoring questionnaire for oral anticancer medication
American Journal of Health-System Pharmacy · 2025
DOI: 10.1093/ajhp/zxaf060 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Health-System Pharmacy, 2025. Verfasst von Tiffany Bui und 7 weiteren Autor:innen. Beteiligte Einrichtung: Vanderbilt Specialty Pharmacy, Vanderbilt University Medical Center, Nashville, TN, USA. Hauptthemen laut MEDLINE: Antineoplastic Agents, Electronic Health Records, Pharmacists, Drug Monitoring. Die Arbeit nennt 41 Literaturangaben.
Abstract (Originalsprache)
Purpose
To evaluate the implementation of an electronic early treatment assessment and monitoring (eTEAM) questionnaire within the electronic health record (EHR) patient portal designed to identify early adverse effects to oral anticancer therapy requiring pharmacist intervention.
Methods
This quality improvement analysis used the 5 dimensions of the RE-AIM implementation science framework to assess use of an innovative eTEAM questionnaire sent to patients 7 to 14 days after initial counseling on oral anticancer therapy. RE-AIM outcomes included the following: reach and adoption: the number of eTEAM questionnaires sent and the number of eTEAM responses received; effectiveness: the number of pharmacist interventions resulting from the eTEAM questionnaire; implementation: pharmacist responses to a postimplementation survey and semistructured individual interviews; maintenance: responses from postimplementation semistructured individual interviews with pharmacists. Results are reported descriptively.
Results
Of the 182 patients sent an eTEAM questionnaire, 47% (n = 85) responded. Pharmacists performed 29 interventions in 25 responding patients, most often due to adverse effects (n = 25) or adherence (n = 4). Most pharmacists agreed that the eTEAM questionnaire was appealing and feasible to use and that its use positively impacted their practice and patient care. Pharmacists recommended that the eTEAM questionnaire be improved by standardizing documentation of patients’ actual oral anticancer medication start date in a discrete field.
Conclusion
The eTEAM questionnaire was positively received by patients, and pharmacists were supportive of its continued use based on feasibility and impact on practice. The eTEAM questionnaire effectively identified opportunities for pharmacist interventions in patients starting oral anticancer medications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vanderbilt Specialty Pharmacy, Vanderbilt University Medical Center, Nashville, TN, USA.
- Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
- Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.
ORCID-Profile: Kristen Whelchel, Leena Choi
Zitieren
APA
Bui, T., Looney, B., DeClercq, J., Lynch, B., Whelchel, K., Nelson, S., Choi, L., & D Zuckerman, A. (2025). Implementation of an electronic early treatment assessment and monitoring questionnaire for oral anticancer medication. American Journal of Health-System Pharmacy. https://doi.org/10.1093/ajhp/zxaf060
Vancouver
Bui T, Looney B, DeClercq J, Lynch B, Whelchel K, Nelson S, et al. Implementation of an electronic early treatment assessment and monitoring questionnaire for oral anticancer medication. American Journal of Health-System Pharmacy. 2025. doi:10.1093/ajhp/zxaf060
BibTeX
@article{Bui2025,
author = {Bui, Tiffany and Looney, Brooke and DeClercq, Josh and Lynch, Bridget and Whelchel, Kristen and Nelson, Scott and Choi, Leena and D Zuckerman, Autumn},
title = {Implementation of an electronic early treatment assessment and monitoring questionnaire for oral anticancer medication},
journal = {American Journal of Health-System Pharmacy},
year = {2025},
doi = {10.1093/ajhp/zxaf060}
}
EUVIMED